Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > NTRK1(Gene name) > Human
  • Add your favorite
  • NTRK1 (Gene name),
  • High affinity nerve growth factor receptor (Protein name ),  NTRK1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    NTRK1(TRK;TRK;TRKA);
    Protein name:
    High affinity nerve growth factor receptor;
    Alternative:
    TRK1-transforming tyrosine kinase protein;Neurotrophic tyrosine kinase receptor type 1;Tyrosine kinase receptor;p140-TrkA(Trk-A);gp140trk;Tyrosine kinase receptor A(Trk-A);p140-TrkA;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Binds SH2B2. Interacts with SQSTM1 which bridges NTRK1 to NGFR. Interacts with KIDINS220 and NGFR. Can form a ternary complex with NGFR and KIDINS220 and this complex is affected by the expression levels of KIDINS220. An increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1.
    Function:
    Required for high-affinity binding to nerve growth factor (NGF), neurotrophin-3 and neurotrophin-4/5 but not brain-derived neurotrophic factor (BDNF). Known substrates for the Trk receptors are SHC1, PI 3-kinase, and PLC-gamma-1. Has a crucial role in the development and function of the nociceptive reception system as well as establishment of thermal regulation via sweating. Activates ERK1 by either SHC1- or PLC-gamma-1-dependent signaling pathway.
    Subcellular Location:
    Cell membrane Single-pass type I membrane protein Endocytosed to the endosomes upon treatment of cells with NGF.
    Protein Attributes:
    Sequence length:
    796
    Sequence:
    50:
    MLRGGRRGQL | GWHSWAAGPG | SLLAWLILAS | AGAAPCPDAC | CPHGSSGLRC | 
    100:
    TRDGALDSLH | HLPGAENLTE | LYIENQQHLQ | HLELRDLRGL | GELRNLTIVK | 
    150:
    SGLRFVAPDA | FHFTPRLSRL | NLSFNALESL | SWKTVQGLSL | QELVLSGNPL | 
    200:
    HCSCALRWLQ | RWEEEGLGGV | PEQKLQCHGQ | GPLAHMPNAS | CGVPTLKVQV | 
    250:
    PNASVDVGDD | VLLRCQVEGR | GLEQAGWILT | ELEQSATVMK | SGGLPSLGLT | 
    300:
    LANVTSDLNR | KNVTCWAEND | VGRAEVSVQV | NVSFPASVQL | HTAVEMHHWC | 
    350:
    IPFSVDGQPA | PSLRWLFNGS | VLNETSFIFT | EFLEPAANET | VRHGCLRLNQ | 
    400:
    PTHVNNGNYT | LLAANPFGQA | SASIMAAFMD | NPFEFNPEDP | IPVSFSPVDT | 
    450:
    NSTSGDPVEK | KDETPFGVSV | AVGLAVFACL | FLSTLLLVLN | KCGRRNKFGI | 
    500:
    NRPAVLAPED | GLAMSLHFMT | LGGSSLSPTE | GKGSGLQGHI | IENPQYFSDA | 
    550:
    CVHHIKRRDI | VLKWELGEGA | FGKVFLAECH | NLLPEQDKML | VAVKALKEAS | 
    600:
    ESARQDFQRE | AELLTMLQHQ | HIVRFFGVCT | EGRPLLMVFE | YMRHGDLNRF | 
    650:
    LRSHGPDAKL | LAGGEDVAPG | PLGLGQLLAV | ASQVAAGMVY | LAGLHFVHRD | 
    700:
    LATRNCLVGQ | GLVVKIGDFG | MSRDIYSTDY | YRVGGRTMLP | IRWMPPESIL | 
    750:
    YRKFTTESDV | WSFGVVLWEI | FTYGKQPWYQ | LSNTEAIDCI | TQGRELERPR | 
    796:
    ACPPEVYAIM | RGCWQREPQQ | RHSIKDVHAR | LQALAQAPPV | YLDVLG
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    MIM:
    SMR:
    Pfam:
    String:
    UniGene:
    Uniprot:
     
    FOR
    ELISA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    E9557h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    E9557m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human High affinity nerve growth factor receptor
    MSDS:
    Please sign in first.
    ELISA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    E9557r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human High affinity nerve growth factor receptor
    MSDS:
    Please sign in first.
    CLIA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    U9557r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    U9557m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human High affinity nerve growth factor receptor
    Cat.:
    U9557h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human High affinity nerve growth factor receptor
    Cat.:
    P9557Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human High affinity nerve growth factor receptor
    Cat.:
    P9557Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human High affinity nerve growth factor receptor
    Polyclonal Antibody for Human High affinity nerve growth factor receptor
    Monoclonal Antibody for Human High affinity nerve growth factor receptor
    Monoclonal Antibody for Human High affinity nerve growth factor receptor
    Monoclonal Antibody for Human High affinity nerve growth factor receptor
    Monoclonal Antibody for Human High affinity nerve growth factor receptor
    Protein for Human High affinity nerve growth factor receptor
    Protein for Human High affinity nerve growth factor receptor
    Protein for Human High affinity nerve growth factor receptor
    Protein for Human High affinity nerve growth factor receptor

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Molecular and biochemical characterization of the human trk proto-oncogene."
      Martin-Zanca D. , Oskam R. , Mitra G. , Copeland T.D. , Barbacid M.
      Mol. Cell. Biol.9:24-33(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKA-I)
      tissue: Colon.
    2. 2.
      "Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins."
      Shelton D.L. , Sutherland J. , Gripp J. , Camerato T. , Armanini M.P. , Phillips H.S. , Carroll K. , Spencer S.D. , Levinson A.D.
      J. Neurosci.15:477-491(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
      tissue: Brain.
    3. 3.
      "Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor."
      Indo Y. , Mardy S. , Tsuruta M. , Karim M.A. , Matsuda I.
      Jpn. J. Hum. Genet.42:343-351(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    4. 4.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TRKA-II);NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-175 (ISOFORM 3)
      tissue: Uterus.
    5. 5.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS TRKA-I AND TRKA-II)
      tissue: Brain.
    7. 7.
      "Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression."
      Fujimoto M. , Kitazawa R. , Maeda S. , Kitazawa S.
      Oncogene24:5108-5118(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71
    8. 8.
      "A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences."
      Martin-Zanca D. , Hughes S.H. , Barbacid M.
      Nature319:743-748(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 399-796;CHROMOSOMAL TRANSLOCATION WITH TPM3
    9. 9.
      "Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences."
      Kozma S.C. , Redmond S.M.S. , Saurer S.M. , Groner B. , Hynes N.E.
      EMBO J.7:147-154(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 399-796
    10. 10.
      "The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain."
      Greco A. , Mariani C. , Miranda C. , Lupas A. , Pagliardini S. , Pomati M. , Pierotti M.A.
      Mol. Cell. Biol.15:6118-6127(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 399-796;CHROMOSOMAL TRANSLOCATION WITH TFG
    11. 11.
      "TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas."
      Greco A. , Pierotti M.A. , Bongarzone I. , Pagliardini S. , Lanzi C. , Della Porta G.
      Oncogene7:237-242(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 486-796;CHROMOSOMAL REARRANGEMENT WITH TPR
    12. 12.
      "High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor."
      Hempstead B.L. , Martin-Zanca D. , Kaplan D.R. , Parada L.F. , Chao M.V.
      Nature350:678-683(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS RECEPTOR FOR NGF
    13. 13.
      "The trk proto-oncogene encodes a receptor for nerve growth factor."
      Klein R. , Jing S. , Nanduri V. , O'Rourke E. , Barbacid M.
      Cell65:189-197(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN NGF SIGNALING;IDENTIFICATION AS THE HIGH AFFINITY NGF RECEPTOR
    14. 14.
      "Tissue-specific alternative splicing generates two isoforms of the trkA receptor."
      Barker P.A. , Lomen-Hoerth C. , Gensch E.M. , Meakin S.O. , Glass D.J. , Shooter E.M.
      J. Biol. Chem.268:15150-15157(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ALTERNATIVE SPLICING (ISOFORMS TRKA-I AND TRKA-II);FUNCTION IN CELL SURVIVAL;NGF-BINDING;PHOSPHORYLATION;TISSUE SPECIFICITY
    15. 15.
      "A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-gamma 1 abolishes NGF-promoted peripherin induction but not neurite outgrowth."
      Loeb D.M. , Stephens R.M. , Copeland T.D. , Kaplan D.R. , Greene L.A.
      J. Biol. Chem.269:8901-8910(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-791;INTERACTION WITH PLCG1;MUTAGENESIS OF TYR-791
    16. 16.
      "Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses."
      Stephens R.M. , Loeb D.M. , Copeland T.D. , Pawson T. , Greene L.A. , Kaplan D.R.
      Neuron12:691-705(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN NEURONAL DIFFERENTIATION;FUNCTION IN PHOSPHORYLATION OF SHC1 AND PLCG1;INTERACTION WITH SHC1;MUTAGENESIS OF TYR-496; LYS-544 AND TYR-791;PHOSPHORYLATION AT TYR-496 AND TYR-791
    17. 17.
      "The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor."
      Wooten M.W. , Seibenhener M.L. , Mamidipudi V. , Diaz-Meco M.T. , Barker P.A. , Moscat J.
      J. Biol. Chem.276:7709-7712(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN NF-KAPPA-B ACTIVATION;INTERACTION WITH SQSTM1
    18. 18.
      "TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma."
      Tacconelli A. , Farina A.R. , Cappabianca L. , Desantis G. , Tessitore A. , Vetuschi A. , Sferra R. , Rucci N. , Argenti B. , Screpanti I. , Gulino A. , Mackay A.R.
      Cancer Cell6:347-360(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN NEURONAL CELL PROLIFERATION AND DIFFERENTIATION;FUNCTION IN SIGNALING CASCADE ACTIVATION;NGF-BINDING;SUBCELLULAR LOCATION;ALTERNATIVE SPLICING (ISOFORM TRKA-III);CHARACTERIZATION OF ISOFORM TRKA-III;PHOSPHORYLATION AT TYR-496; TYR-680; TYR-681 AND TYR-791;INTERACTION WITH FRS2; GRB2; PIK3R1; PLCG1; SHC1;GLYCOSYLATION;TISSUE SPECIFICITY;INDUCTION BY HYPOXIA
    19. 19.
      "Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling."
      Vaegter C.B. , Jansen P. , Fjorback A.W. , Glerup S. , Skeldal S. , Kjolby M. , Richner M. , Erdmann B. , Nyengaard J.R. , Tessarollo L. , Lewin G.R. , Willnow T.E. , Chao M.V. , Nykjaer A.
      Nat. Neurosci.14:54-61(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SORT1;ENZYME REGULATION
    20. 20.
      "Structure and ligand recognition of the phosphotyrosine binding domain of Shc."
      Zhou M.-M. , Ravichandran K.S. , Olejniczak E.F. , Petros A.M. , Meadows R.P. , Sattler M. , Harlan J.E. , Wade W.S. , Burakoff S.J. , Fesik S.W.
      Nature378:584-592(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 489-500
    21. 21.
      "Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC."
      Ultsch M.H. , Wiesmann C. , Simmons L.C. , Henrich J. , Yang M. , Reilly D. , Bass S.H. , de Vos A.M.
      J. Mol. Biol.290:149-159(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 278-386
    22. 22.
      "Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor."
      Wiesmann C. , Ultsch M.H. , Bass S.H. , de Vos A.M.
      Nature401:184-188(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 282-382
    23. 23.
      "Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors."
      Wehrman T. , He X. , Raab B. , Dukipatti A. , Blau H. , Garcia K.C.
      Neuron53:25-38(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 36-382 IN COMPLEX WITH NGF;HOMODIMERIZATION;DISULFIDE BONDS;GLYCOSYLATION AT ASN-95; ASN-121; ASN-188; ASN-262; ASN-281 AND ASN-358
    24. 24.
      "Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis."
      Indo Y. , Tsuruta M. , Hayashida Y. , Karim M.A. , Ohta K. , Kawano T. , Mitsubuchi H. , Tonoki H. , Awaya Y. , Matsuda I.
      Nat. Genet.13:485-488(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA ARG-577
    25. 25.
      "A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis."
      Greco A. , Villa R. , Tubino B. , Romano L. , Penso D. , Pierotti M.A.
      Am. J. Hum. Genet.64:1207-1210(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA PRO-780
    26. 26.
      "Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor."
      Mardy S. , Miura Y. , Endo F. , Matsuda I. , Sztriha L. , Frossard P. , Moosa A. , Ismail E.A.R. , Macaya A. , Andria G. , Toscano E. , Gibson W. , Graham G.E. , Indo Y.
      Am. J. Hum. Genet.64:1570-1579(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CIPA PRO-213; TRP-649 AND SER-714;VARIANTS SER-85; TYR-604 AND VAL-613
    27. 27.
      "Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma."
      Gimm O. , Greco A. , Hoang-Vu C. , Dralle H. , Pierotti M.A. , Eng C.
      J. Clin. Endocrinol. Metab.84:2784-2787(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS TYR-604; VAL-613 AND GLN-780
    28. 28.
      "A novel point mutation affecting the tyrosine kinase domain of the TRKA gene in a family with congenital insensitivity to pain with anhidrosis."
      Yotsumoto S. , Setoyama M. , Hozumi H. , Mizoguchi S. , Fukumaru S. , Kobayashi K. , Saheki T. , Kanzaki T.
      J. Invest. Dermatol.112:810-814(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA VAL-587
    29. 29.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS TYR-604 AND VAL-613
    30. 30.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    31. 31.
      "Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and results of nerve conduction studies."
      Shatzky S. , Moses S. , Levy J. , Pinsk V. , Hershkovitz E. , Herzog L. , Shorer Z. , Luder A. , Parvari R.
      Am. J. Med. Genet.92:353-360(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA LEU-695;VARIANT VAL-613
      tissue: Peripheral blood.
    32. 32.
      "Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families."
      Miura Y. , Mardy S. , Awaya Y. , Nihei K. , Endo F. , Matsuda I. , Indo Y.
      Hum. Genet.106:116-124(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CIPA PRO-93; ARG-522; ARG-577; CYS-654 AND TYR-674
    33. 33.
      "The Gly571Arg mutation, associated with the autonomic and sensory disorder congenital insensitivity to pain with anhidrosis, causes the inactivation of the NTRK1/nerve growth factor receptor."
      Greco A. , Villa R. , Fusetti L. , Orlandi R. , Pierotti M.A.
      J. Cell. Physiol.182:127-133(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA ARG-577
    34. 34.
      "A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V."
      Houlden H. , King R.H. , Hashemi-Nejad A. , Wood N.W. , Mathias C.J. , Reilly M. , Thomas P.K.
      Ann. Neurol.49:521-525(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CIPA CYS-359;VARIANTS TYR-604 AND VAL-613
    35. 35.
      "Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor."
      Mardy S. , Miura Y. , Endo F. , Matsuda I. , Indo Y.
      Hum. Mol. Genet.10:179-188(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANTS CIPA PRO-93; PRO-213; ARG-522; ARG-577; TRP-649; CYS-654 AND SER-714;CHARACTERIZATION OF VARIANTS SER-85; TYR-604; VAL-613 AND TYR-674
    36. 36.
      "Patterns of somatic mutation in human cancer genomes."
      Greenman C. , Stephens P. , Smith R. , Dalgliesh G.L. , Hunter C. , Bignell G. , Davies H. , Teague J. , Butler A. , Stevens C. , Edkins S. , O'Meara S. , Vastrik I. , Schmidt E.E. , Avis T. , Barthorpe S. , Bhamra G. , Buck G. , more...
      Nature446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] ARG-80; VAL-107; MET-237; GLY-238; GLY-260; GLN-444; CYS-452; THR-566; TYR-604; VAL-613; GLN-780 AND ILE-790
    37. 37.
      "Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort."
      Davidson G.L. , Murphy S.M. , Polke J.M. , Laura M. , Salih M.A. , Muntoni F. , Blake J. , Brandner S. , Davies N. , Horvath R. , Price S. , Donaghy M. , Roberts M. , Foulds N. , Ramdharry G. , Soler D. , Lunn M.P. , Manji H. , more...
      J. Neurol.259:1673-1685(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CIPA LYS-492 AND CYS-654;VARIANT TRP-6
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter